Busulfan plus melphalan versus high-dose melphalan as conditioning regimens in autologous stem cell transplantation for newly diagnosed multiple myeloma

BACKGROUND: High-dose melphalan (HDMEL) represents the standard conditioning regimen before autologous stem cell transplant (ASCT) in multiple myeloma (MM), but recent updates have suggested combination of melphalan with bulsulfan (BUMEL) is also associated with favorable outcomes. We performed the...

Descripción completa

Detalles Bibliográficos
Autores principales: Byun, Ja Min, Lee, Jayoun, Shin, Sang-Jin, Kang, Minjoo, Yoon, Sung-Soo, Koh, Youngil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6021568/
https://www.ncbi.nlm.nih.gov/pubmed/29963515
http://dx.doi.org/10.5045/br.2018.53.2.105

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6021568/
https://www.ncbi.nlm.nih.gov/pubmed/29963515
http://dx.doi.org/10.5045/br.2018.53.2.105

Ejemplares similares